期刊文献+

EGFR抑制剂C225对人前列腺癌细胞的放射增敏作用

Radiosensitization effect of EGFR inhibitor C225 on prostate cancer cell
原文传递
导出
摘要 目的探讨表皮生长因子抑制剂C225对人前列腺癌细胞株(DU145)放射敏感性的影响。方法实验组用表皮生长因子抑制剂C225(100nmol/L)处理后,^60Coγ射线(吸收剂量率1.953Gy/min)对体外培养的DU145细胞进行0、2、4、6和8Gy照射,用MTT法、集落形成法检测细胞增殖和细胞存活率;用单击多靶模型拟合剂量存活曲线;用流式细胞仪检测细胞周期和凋亡。结果C225对照射后DU145细胞增殖有明显抑制作用。C225组的放射生物学参数值(D0、Dq、N、SF2)较对照组低。C225组和对照组的RBE比值为1.39。C225组处于S期的细胞比例降低,出现明显的G0/G1期阻滞。C225组细胞的早期凋亡率在照射剂量达4Gy后明显高于对照组(t=-14.55,P〈0.05)。结论表皮生长因子抑制剂C225通过抑制细胞增殖、G0/G1期阻滞和诱导凋亡来增加人前列腺癌细胞放射敏感性。 Objective To determine the effects of EGFR inhibitor C225 on radiosensitivity of human prostate cancer cells. Methods Human prostate cancer DU145 cells were irradiated with ^60 Co (1. 953 Gy/min) at various doses of 0,2,4,6,8 Gy in the presence or absence of C225 (100 nmol/L). The cellular proliferation and cell surviving rate were evaluated by MTT and the colony-forming assay. The cell cycle distribution and cell apoptosis were tested by flow cytometry. Results C225 caused significant anti-proliferative effect on irradiated DU145 ceils. The radiobiological parameters of C225 group, including D0 , Dq, N, SF2 , were lower than those of control group. The RBE for C225 group compared with control group is 1.39. Cells treated with C225 showed significant G0/G1 phase arrest and a decrease in S phase over the dose of 4 Gy in comparison with the control. Higher apoptosis rate over 4 Gy was observed in C225-treated cells compared to the control ( t = - 14,55, P 〈 0.05). Conclusions EGFR inhibitor C225 could increase the radiosensitivity of DU145 cells through anti- proliferation, G0/G1 phase arrest and apoptosis induction.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2008年第5期452-455,共4页 Chinese Journal of Radiological Medicine and Protection
基金 民政部老年学研究立项资助项目([2007]18号)
关键词 表皮生长因子抑制剂 前列腺癌细胞 细胞周期 凋亡 放射治疗 EGFR inhibitor Prostate cancer cell Cell proliferation Apoptosis Radiation therapy
  • 相关文献

参考文献20

  • 1Kao J, Turian J, Meyers A, et al. Sparing of the penile hulb and proximal penile structures with intensity-modulated .radiation therapy for prostate cancer. Br J Radiol, 2004,77(914) : 129-136.
  • 2Namiki S, Ishidoya S, Tochigi T, et al. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol, 2006,36(4) : 224-230.
  • 3Shuch B, Mikhail M, Satagopan J, et al. Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol, 2004,22(23) : 4725-4729.
  • 4Sok JC, Coppelli FM, Thomas SM, et ai. Mutant epidermal growth factor receptor (EGFRvⅢ) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res, 2006,12 (17) : 5064-5073.
  • 5Italiano A, Vandenbos BF, Otto J, et al. Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors. Ann Onc, 2006,17(6): 981-985.
  • 6Formento P, Hannoun-Levi JM, Gerard F, et al. Gefitinibtrastuzumab combination on hormone-refractory prostate cancer xenograft. Eur J Cancer, 2005,41(10) : 1467-1473.
  • 7Wang Q, Greene MI. EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway. Exp Mol Pathol, 2005,79: 100-107.
  • 8Huang ZQ, Buchsbaum DJ, Raisch KP, et al. Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody. J Surg Res, 2003,111: 274-283.
  • 9Dittmann K, Mayer C, Fehrenbacher B, et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem, 2005,280 (35) : 31182-31189.
  • 10Pan X, Lee RJ. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity. Int J Pharm, 2007,336: 276- 283.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部